Clinical trials for the injectable HIV prevention drug lenacapavir have yielded significant results, with the drug proving 89% more effective than daily oral pre-exposure prophylaxis among gay, bisexual and transgender individuals, NBC News reported Sept. 13. 

The FDA issued a warning regarding the potential risk of a rare but serious liver injury associated with the drug Veozah, a medication approved in May 2023 to treat moderate to severe hot flashes. 

The closure of hundreds of pharmacies by major chains such as Walgreens and Rite Aid could signal a growing crisis in the industry, the executive director of the Ohio Pharmacists Association has said. 

The FDA cited AbbVie for its direct-to-consumer television ad for Ubrelvy, featuring tennis star Serena Williams. 

Sen. Peter Welch (D-Vt.) has introduced  a bill that would ban pharmaceutical companies from restricting access to 340B drug pricing program discounts, according to a Sept. 11 press release shared with Becker's.

In a phase 3 clinical trial, liraglutide was shown to reduce the body mass index in children ages 6 to 11 with obesity, according to a study published Sept. 10 in The New England Journal of Medicine. 

Tralia, the region with the highest rate of skin cancer globally. In recent years, sunscreen hasn’t just become about avoiding skin cancer, but in keeping us young and preventing wrinkles. It has transformed into a 2-in-1 way to moisturize and protect your skin. And, as you learn more about the dangers of UV, it only becomes more important.

AstraZeneca's lung cancer drug datopotamab deruxtecan, also called Dato-DXd, failed to show a significant benefit to overall survival when compared to standard chemotherapy drug docetaxel, according to trial results published Sept. 9 in the Journal of Clinical Oncology. 

AbbVie has filed a lawsuit against BeiGene, alleging the biotechnology company of stealing trade secrets to develop a competing cancer therapy.

In a phase 1/2 trial, researchers tested ATSN-101, a gene therapy for Leber congenital amaurosis 1, a rare genetic disorder that typically causes blindness in early childhood. 

A recent American Medical Association found that 72% of insured individuals are covered by companies owning or closely linked to a pharmacy benefit manager. As a result, the organization is advocating for stronger regulatory oversight. 

While drugmakers Novo Nordisk and Eli Lilly assert that shortages of popular weight loss and diabetes medications Wegovy, Ozempic, Mounjaro and Zepbound are easing, many patients continue to face challenges accessing the drugs, NPR reported Sept. 6. 

Leqembi, an Alzheimer's drug from Biogen and Eisai, faces hurdles with respect to reimbursement and diagnostic uncertainties, diagnostic test requirements and the need for regular brain scans, CNBC reported Sept. 8. 

A federal judge in Baltimore has denied a request by major drug companies to block a new Maryland law that requires them to sell discounts on medications sold through third-party pharmacies affiliated with hospitals and clinics serving low-income populations, Reuter's reported Sept. 6. 

Pharmaceutical company Eli Lilly may become the first healthcare company to hit a market value of $1 trillion, according to a Sept. 5 CNBC report. 

Existing arthritis drugs could help stop lingering lung problems that can last up to years after COVID-19 infections, according to a study from researchers at Charlottesville, Va.-based UVA Health and Los Angeles-based Cedars-Sinai. 

A new study by researchers at Salt Lake City-based University of Utah School of Medicine set out to highlight the environmental costs that come with unnecessary antibiotic prescriptions in outpatient settings. 

After Kentucky pharmacy workers dispensed compounded medications to three children, they were all hospitalized. The Kentucky Board of Pharmacy is investigating the situation. 

The American Hospital Association, 340B Health and the American Society of Health-System Pharmacists filed a motion asking for permission to submit an amicus brief to support the defendants in a lawsuit brought by Novartis Pharmaceuticals. 

As major pharmacy chains start rolling out the new COVID-19 vaccine, independent pharmacies report facing shipment delays, resulting in longer wait times for patient vaccinations, NBC News reported Sept. 5.